i
Review of the revised plan for off-site treatment of Newport Chemical Agent Disposal Facility’s Caustic VX Hydrolysate at the DuPont Secure Environmental Treatment Facility in Deepwater, New Jersey : summary of the report to Congress. Corrected version.
-
07/01/2006
[PDF-2.26 MB]
Details:
-
Corporate Authors:
-
Description:cdc:130732
This report presents the findings of the follow-up review of the U.S. Army proposal for Caustic VX Hydrolysate (CVXH) waste transportation, treatment, and subsequent discharge of treated material into the Delaware River. The U.S. Army’s plan for destroying their stockpile of bulk VX, a nerve agent developed for use in chemical warfare results in a treatment byproduct known as CVXH. The review was a joint effort by the Centers for Disease Control and Prevention (CDC) and the U.S. Environmental Protection Agency (EPA).
In a March 29, 2004, letter to CDC, the four U.S. Senators from New Jersey and Delaware, along with four members of the House of Representatives asked CDC to formally review the proposal for off-site treatment of CVXH to determine “if there is public health risk involved with the Army’s proposal.” This report, referred to as Phase I, identified several limitations of the available data that required resolution (1). They then asked both the U.S. Army and CDC to work together to address the remaining issues from the Phase I report and to review the proposed DuPont phosphonate removal process. The Army and DuPont conducted several studies and submitted the results to CDC and EPA for review.
correctedvxreport06.pdf
-
Subjects:
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
